The aims of the present study were to compare the prognostic significance of matched preoperative plasma and serum VEGF concentrations in patients with CRC and to evaluate whether serum or plasma was the best predictor of overall survival. The gene discussed is VEGFA; the disease is colorectal carcinoma.